Health

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy – News-Medical.Net

The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen,…

Published

4 years ago

August 3, 2021

Noosa Online News Publisher

The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen™, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate…

Click here to view the original article.

Related Topics:Australia News-Medical.Net

Up Next

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study – The Lancet

Don't Miss

A study identified 15 novel biomarkers for diseases predisposing to dementia – Science Daily

Noosa News7 hours ago

NRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs